Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1995 Jul;41:1222–1228.

Preventing hepatitis A infections. National Advisory Committee on Immunization statement. Laboratory Centre for Disease Control.

PMCID: PMC2146187  PMID: 7647629

Full text

PDF
1222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrosch F., André F. E., Delem A., D'Hondt E., Jonas S., Kunz C., Safary A., Wiedermann G. Simultaneous vaccination against hepatitis A and B: results of a controlled study. Vaccine. 1992;10 (Suppl 1):S142–S145. doi: 10.1016/0264-410x(92)90570-a. [DOI] [PubMed] [Google Scholar]
  2. André F. E., D'Hondt E., Delem A., Safary A. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings. Vaccine. 1992;10 (Suppl 1):S160–S168. doi: 10.1016/0264-410x(92)90576-6. [DOI] [PubMed] [Google Scholar]
  3. Berger R., Just M. Vaccination against hepatitis A: control 3 years after the first vaccination. Vaccine. 1992;10(4):295–295. doi: 10.1016/0264-410x(92)90287-t. [DOI] [PubMed] [Google Scholar]
  4. Delem A., Safary A., De Namur F., Hauser P., D'Hondt E. Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis A. Vaccine. 1993;11(4):479–484. doi: 10.1016/0264-410x(93)90291-5. [DOI] [PubMed] [Google Scholar]
  5. Flehmig B., Heinricy U., Pfisterer M. Prospects for a hepatitis A virus vaccine. Prog Med Virol. 1990;37:56–71. [PubMed] [Google Scholar]
  6. Green M. S., Cohen D., Lerman Y., Sjogren M., Binn L. N., Zur S., Slepon R., Robin G., Hoke C., Bancroft W. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. J Infect Dis. 1993 Sep;168(3):740–743. doi: 10.1093/infdis/168.3.740. [DOI] [PubMed] [Google Scholar]
  7. Halliday M. L., Kang L. Y., Zhou T. K., Hu M. D., Pan Q. C., Fu T. Y., Huang Y. S., Hu S. L. An epidemic of hepatitis A attributable to the ingestion of raw clams in Shanghai, China. J Infect Dis. 1991 Nov;164(5):852–859. doi: 10.1093/infdis/164.5.852. [DOI] [PubMed] [Google Scholar]
  8. Krushak D. H. Application of preventive health measures to curtail chimpanzee-associated infectious hepatitis in handlers. Lab Anim Care. 1970 Feb;20(1):52–56. [PubMed] [Google Scholar]
  9. Lange W. R., Frame J. D. High incidence of viral hepatitis among American missionaries in Africa. Am J Trop Med Hyg. 1990 Nov;43(5):527–533. doi: 10.4269/ajtmh.1990.43.527. [DOI] [PubMed] [Google Scholar]
  10. Lemon S. M. Type A viral hepatitis. New developments in an old disease. N Engl J Med. 1985 Oct 24;313(17):1059–1067. doi: 10.1056/NEJM198510243131706. [DOI] [PubMed] [Google Scholar]
  11. Scheifele D. W., Bjornson G. J. Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more. CMAJ. 1993 Feb 15;148(4):551–555. [PMC free article] [PubMed] [Google Scholar]
  12. Wagner G., Lavanchy D., Darioli R., Pécoud A., Brulein V., Safary A., Frei P. C. Simultaneous active and passive immunization against hepatitis A studied in a population of travellers. Vaccine. 1993;11(10):1027–1032. doi: 10.1016/0264-410x(93)90128-k. [DOI] [PubMed] [Google Scholar]
  13. Wiedermann G., Ambrosch F., André F. E., D'Hondt E., Delem A., Safary A. Persistence of vaccine-induced antibody to hepatitis A virus. Vaccine. 1992;10 (Suppl 1):S129–S131. doi: 10.1016/0264-410x(92)90566-3. [DOI] [PubMed] [Google Scholar]
  14. Winokur P. L., Stapleton J. T. Immunoglobulin prophylaxis for hepatitis A. Clin Infect Dis. 1992 Feb;14(2):580–586. doi: 10.1093/clinids/14.2.580. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES